Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …

Therapeutic peptides are oligomers or short polymers of amino acids used for various
medical purposes. Peptide-based treatments have evolved considerably due to new …

Background There are no studies specifically designed to rule out a drug-drug interaction
(DDI) when cangrelor is used among patients who have been pretreated with ticagrelor …

Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary
intervention–related ischemic complications without increasing major bleeding. This study …

Localized chemotherapy is emerging as a potential strategy for cancer treatment due to its
low systemic toxicity. However, the immune evasion of tumor cells and the lack of an …

Introduction Non-ST-segment elevation acute coronary syndromes (NSTE-ACS), including
non-ST-segment-elevation myocardial infarction (NSTEMI) and unstable angina, represent a …

Vascular stenosis caused by atherosclerosis instigates activation and aggregation of
platelets, eventually resulting in thrombus formation. Although antiplatelet drugs are …

Background The optimal antiplatelet therapy regimen for certain neuroendovascular
procedures remains unclear. This study investigates the safety and feasibility of intravenous …

The use of intravenous antiplatelet therapy during primary percutaneous coronary
intervention (PPCI) is not fully standardized. The aim is to evaluate the effectiveness and …

Background Extracorporeal membrane oxygenation (ECMO) is a vital technique for severe
respiratory or heart failure patients. Bleeding and thrombotic events are common during …